Literature DB >> 28005484

State Health Department Requirements for Reporting of Antibiotic-Resistant Infections by Providers, United States, 2013 and 2015.

Monika Pogorzelska-Maziarz1, Eileen J Carter2,3, Mary Lou Manning1, Elaine L Larson2.   

Abstract

Due to the high burden of antibiotic-resistant infections, several US states mandate public reporting of these infections. To examine the extent to which state departments of health require reporting of antibiotic-resistant infections, we abstracted data from lists of reportable conditions from all 50 states at 2 time points, May 2013 and May 2015. Requirements varied substantially by state. In 2015, most states (n = 44) required reporting of at least 1 antibiotic-resistant infection; vancomycin-intermediate and/or vancomycin-resistant Staphylococcus aureus was the most frequently reportable infection (n = 40). Few states required reporting of methicillin-resistant S aureus (n = 11), multidrug-resistant gram-negative bacteria (n = 9), or vancomycin-resistant enterococci (n = 8). During the 2 years we studied, 2013 and 2015, 4 states removed and 9 added at least 1 reporting requirement. The changes in reporting requirements suggest flexibility in health departments' response to local surveillance needs and emerging threats. Future studies should assess how data on antibiotic-resistant infections through different sources are used at the state level to drive prevention and control efforts.

Entities:  

Keywords:  antibiotic-resistant infections; notifiable conditions; public health reporting

Mesh:

Substances:

Year:  2016        PMID: 28005484      PMCID: PMC5298509          DOI: 10.1177/0033354916681507

Source DB:  PubMed          Journal:  Public Health Rep        ISSN: 0033-3549            Impact factor:   2.792


  4 in total

1.  Mandatory reporting of diseases and conditions by health care professionals and laboratories.

Authors:  S Roush; G Birkhead; D Koo; A Cobb; D Fleming
Journal:  JAMA       Date:  1999-07-14       Impact factor: 56.272

Review 2.  Laws pertaining to healthcare-associated infections: a review of 3 legal requirements.

Authors:  Julie Reagan; Carl Hacker
Journal:  Infect Control Hosp Epidemiol       Date:  2011-11-11       Impact factor: 3.254

Review 3.  State-mandated reporting of health care-associated infections in the United States: trends over time.

Authors:  Carolyn T A Herzig; Julie Reagan; Monika Pogorzelska-Maziarz; Divya Srinath; Patricia W Stone
Journal:  Am J Med Qual       Date:  2014-06-20       Impact factor: 1.852

4.  Extended-Spectrum β-Lactamase-Producing and Third-Generation Cephalosporin-Resistant Enterobacteriaceae in Children: Trends in the United States, 1999-2011.

Authors:  Latania K Logan; Nikolay P Braykov; Robert A Weinstein; Ramanan Laxminarayan
Journal:  J Pediatric Infect Dis Soc       Date:  2014-03-19       Impact factor: 3.164

  4 in total
  4 in total

1.  Bioinspired Photocatalytic Shark-Skin Surfaces with Antibacterial and Antifouling Activity via Nanoimprint Lithography.

Authors:  Feyza Dundar Arisoy; Kristopher W Kolewe; Benjamin Homyak; Irene S Kurtz; Jessica D Schiffman; James J Watkins
Journal:  ACS Appl Mater Interfaces       Date:  2018-06-01       Impact factor: 9.229

Review 2.  New Threats from an Old Foe: Methicillin-Resistant Staphylococcus aureus Infections in Neonates.

Authors:  Ying Dong; Kirsten Glaser; Christian P Speer
Journal:  Neonatology       Date:  2018-05-25       Impact factor: 4.035

3.  The expansion of National Healthcare Safety Network enrollment and reporting in nursing homes: Lessons learned from a national qualitative study.

Authors:  Patricia W Stone; Ashley M Chastain; Richard Dorritie; Aluem Tark; Andrew W Dick; Jeneita M Bell; Nimalie D Stone; Denise D Quigley; Melony E Sorbero
Journal:  Am J Infect Control       Date:  2019-03-06       Impact factor: 2.918

4.  Impact of multicenter unified enhanced environmental cleaning and disinfection measures on nosocomial infections among patients in intensive care units.

Authors:  Jing Huang; Can Cui; Shuli Zhou; Ming Chen; Hao Wu; Ronghua Jin; Xinyue Chen
Journal:  J Int Med Res       Date:  2020-08       Impact factor: 1.671

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.